113 related articles for article (PubMed ID: 10322411)
1. Modification of Chromatin Structure by the Thyroid Hormone Receptor.
Li Q; Sachs L; Shi YB; Wolffe AP
Trends Endocrinol Metab; 1999 May; 10(4):157-164. PubMed ID: 10322411
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor, v-ErbA, and chromatin.
Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
[TBL] [Abstract][Full Text] [Related]
3. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
[TBL] [Abstract][Full Text] [Related]
4. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase.
Wong J; Patterton D; Imhof A; Guschin D; Shi YB; Wolffe AP
EMBO J; 1998 Jan; 17(2):520-34. PubMed ID: 9430643
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
6. Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development.
Sachs LM; Shi YB
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13138-43. PubMed ID: 11078533
[TBL] [Abstract][Full Text] [Related]
7. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
8. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
9. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.
Ishii S; Yamada M; Satoh T; Monden T; Hashimoto K; Shibusawa N; Onigata K; Morikawa A; Mori M
Mol Endocrinol; 2004 Jul; 18(7):1708-20. PubMed ID: 15131262
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone receptor coactivators and corepressors.
Koenig RJ
Thyroid; 1998 Aug; 8(8):703-13. PubMed ID: 9737367
[TBL] [Abstract][Full Text] [Related]
11. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo.
Sharma D; Fondell JD
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7934-9. PubMed ID: 12034878
[TBL] [Abstract][Full Text] [Related]
12. A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor.
Wong J; Shi YB; Wolffe AP
Genes Dev; 1995 Nov; 9(21):2696-711. PubMed ID: 7590246
[TBL] [Abstract][Full Text] [Related]
13. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
14. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription.
Collingwood TN; Urnov FD; Wolffe AP
J Mol Endocrinol; 1999 Dec; 23(3):255-75. PubMed ID: 10601972
[TBL] [Abstract][Full Text] [Related]
16. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation.
Liu Y; Xia X; Fondell JD; Yen PM
Mol Endocrinol; 2006 Mar; 20(3):483-90. PubMed ID: 16254015
[TBL] [Abstract][Full Text] [Related]
18. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
19. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor.
Lutz M; Baniahmad A; Renkawitz R
Biochem Soc Trans; 2000; 28(4):386-9. PubMed ID: 10961925
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
